First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Norepinephrine

This is a "connection" page, showing publications Karl-Erik Andersson has written about Norepinephrine.
Connection Strength

0.206
  1. Hennenberg M, Strittmatter F, Beckmann C, Rutz B, Füllhase C, Waidelich R, Montorsi F, Hedlund P, Andersson KE, Stief CG, Gratzke C. Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. PLoS One. 2012; 7(11):e50904.
    View in: PubMed
    Score: 0.092
  2. Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003 Aug; 170(2 Pt 2):S6-13; discussion S13-4.
    View in: PubMed
    Score: 0.048
  3. Andersson KE. Treatment of the overactive bladder: possible central nervous system drug targets. Urology. 2002 May; 59(5 Suppl 1):18-24.
    View in: PubMed
    Score: 0.044
  4. Bauer RM, Strittmatter F, Gratzke C, Göttinger J, Schlenker B, Reich O, Stief CG, Hedlund P, Andersson KE, Hennenberg M. Coupling of a1-adrenoceptors to ERK1/2 in the human prostate. Urol Int. 2011; 86(4):427-33.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.